Best deal of the week
DR. DOPING

Instructions

Logo DR. DOPING

Instruction for use: Metoprolol Organica

I want this, give me price

Trade name of the drug – Metoprolol Organica

Dosage Form: tablets

Active substance:Metoprololum

ATX

C07AB02 Metoprolol

Pharmacotherapeutic group: Beta-blockers

The nosological classification (ICD-10)

E05.9 Thyrotoxicosis, unspecified: tireotoksicski reaction; Enlargement of the thyroid gland with symptoms of hyperthyroidism; The phenomenon of iodine Basedow; Thyroid hyperplasia; hyperthyroid state; Hyperthyroidism; Thyroid dysfunction; Diffuse thyrotoxic goiter; The latent thyrotoxicosis; Increased thyroid function; thyrotoxicosis

G43 Migraine: The pain of migraine; Migraine; hemiplegic migraine; Migraine headache; A migraine attack; Continuous headache; hemicrania

I10 Essential (primary) hypertension: hypertension; Arterial hypertension; Arterial hypertension crisis course; Essential Hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Primary hypertension; Arterial hypertension, complications of diabetes; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; arterial Hypertension; malignant Hypertension; Hypertonic disease; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; Isolated systolic hypertension

I15 Secondary hypertension: Arterial hypertension, complications of diabetes; hypertension; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; hypertension; arterial Hypertension; malignant Hypertension; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; hypertension; Arterial hypertension; Arterial hypertension crisis course; renovascular hypertension; Hypertension symptomatic; Renal hypertension; Renovascular hypertension; renovascular hypertension; Symptomatic hypertension

I20 Angina [angina]: Heberden disease; Angina pectoris; The attack of angina pectoris; recurrent angina; Spontaneous angina; Stable angina pectoris; Angina rest; Angina progressing; Angina mixed; Angina spontaneous; stable angina; Chronic stable angina; Angina Syndrome X

I25.2 Transferred last myocardial infarction: Cardiac syndrome; Myocardial infarction; post-MI; Rehabilitation after myocardial infarction; Reocclusion of the operated vessel; Angina postinfarctnaya; Status after myocardial infarction; Status after myocardial infarction; myocardial infarction

I25.9 Chronic ischemic heart disease, unspecified: CHD; Insufficiency of coronary circulation; Coronary atherosclerosis in patients with coronary artery disease

I47.1 Supraventricular tachycardia: Supraventricular paroxysmal tachycardia; supraventricular tachyarrhythmia; supraventricular tachycardia; Supraventricular arrhythmias; Supraventricular paroxysmal tachycardia; supraventricular tachyarrhythmias; supraventricular tachycardia; Neurogenic sinus tachycardia; orthodromic tachycardia; Paroxysmal supraventricular tachycardia; Paroxysm of supraventricular tachycardia; Paroxysm of supraventricular tachycardia with WPW-syndrome; Paroxysm of atrial tachycardia; Paroxysmal supraventricular tachyarrhythmia; Paroxysmal supraventricular tachycardia; Politopnye atrial tachycardia; Atrial fibrillation; Atrial tachycardia is true; Atrial tachycardia; Atrial tachycardia with AV block; reperfusion arrhythmias; Reflex Bertsolda-Jarisch; Recurrent sustained supraventricular paroxysmal tachycardia; Symptomatic ventricular tachycardia; Sinus tachycardia; Supraventricular paroxysmal tachycardia; supraventricular tachyarrhythmia; supraventricular tachycardia; supraventricular arrhythmia; supraventricular arrhythmias; Tachycardia of AV connections; supraventricular tachycardia; Tachycardia orthodromic; sinus tachycardia; The nodal tachycardia; Chaotic atrial tachycardia politopnye; Wolff-Parkinson-White

I49.3 Premature ventricular depolarization: Asynergia left ventricle; ventricular Arrhythmia; Pronounced PVCs; fibrillation; ventricular beat; ventricular beat; Ventricular arrhythmias; ventricular beat; Paroxysmal ventricular arrythmia; Recurrent ventricular arrhythmias; ventricular premature beats; Asynergia ventricular

I49.9 Irregular heartbeat, unspecified: Paroxysmal supraventricular tachycardia; extrasystole arrhythmia; Atrial fibrillation tachysystolic; supraventricular tachyarrhythmia; supraventricular arrhythmias; AV reciprocating tachycardia; AV-nodal reciprocating tachycardia; ventricular fibrillation; Irregular heartbeat; Antidromic reciprocating tachycardia; Cardiac arrhythmias; Arrhythmias; Arrhythmia; Heart arythmy; Arrhythmia due to hypokalemia; ventricular tachyarrhythmias; The high frequency of ventricular contraction; Cardiac arrhythmias; Paroxysmal supraventricular arrhythmia; Paroxysmal supraventricular arrhythmia; Paroxysmal dysrhythmia; Paroxysmal atrial-ventricular rhythm; cardiac arrhythmias; supraventricular tachycardia; tachyarrhythmia; Precordial abnormal pulsation

I99 Other and unspecified disorders of the circulatory system: angiopathy; Arterial angiopathy; Atherosclerotic angiopathy; Hemodynamic right heart defects; Hemodynamic defect of the right heart; coronary angiopathy; Infringement of blood circulation; Violation of circulation; Violation microcirculation in organs and tissues; Peripheral circulatory disorders; Disorders of the peripheral circulation in the extremities; circulatory failure; Hemodynamic instability occlusion of arteriovenous origin; Acute circulatory failure; Psevdostenokardicheskie state; Psevdostenokardicheskoe disorder; circulatory disorder; Cardiovascular diseases; Vascular insufficiency; Thrombosis arteriovenous shunt; Thrombosis with prosthetic heart valves; Deterioration of blood circulation in the pelvic organs; Functional failure of the cardiovascular system; Functional disorders of the cardiovascular system; Chronic arterial insufficiency; Chronic heart failure; Age-related vascular disease; The risk of thrombosis

R00.0 Unspecified Tachycardia: Tachycardia

Composition (per tablet): active substance: metoprolol tartrate 25 mg, 50 mg

excipients: calcium hydrogen phosphate dihydrate - 19.1 / 38.2 mg; sodium carboxymethyl - 8.9 / 17.8 mg; MCC - 34.7 / 69.4 mg; povidone (polyvinylpyrrolidone, high molecular Medical) - 0.3 / 0.6 mg; magnesium stearate - 0.9 / 1.8 mg; colloidal silicon dioxide (Aerosil) - 1.1 / 2.2 mg

Pharmacological Properties of Metoprolol Organica

Pharmachologic effect - antianginal, antihypertensive, anti-arrhythmic.

Dosage and Administration

Inside, along with a meal or immediately after a meal, the tablet can be divided in half, but do not chew and drink the liquid.

Hypertension - the initial daily dose is 50-100 mg in 1-2 divided doses (morning and evening). With insufficient therapeutic effect of the daily dose can be gradually increased to 100-200 mg and / or further assigned other antihypertensives. The maximum daily dose - 200 mg.

Secondary prevention of myocardial infarction - 200 mg / day in 2 divided doses (morning and evening).

Angina pectoris, arrhythmias, migraine prophylaxis - 100-200 mg / day in 2 divided doses (morning and evening).

Functional disorders of cardiac activity, accompanied by palpitations, - 100 mg / day in 2 divided doses (morning and evening).

In hyperthyroidism - 150-200 mg / day in 3-4 divided doses.

In elderly patients with renal (Cl creatinine <40 ml / min), as well as the need for dialysis, the dose does not change.

When expressed violations of liver function the dose should be reduced depending on the clinical condition.

Release Form

Tablets, 25 mg or 50 mg. In blisters made of PVC foil and aluminum foil, 10 pieces. 2, 3, 5, or 6 contour cell packages are placed in a cardboard box.

Manufacturer

"Organic" JSC. 654034, Russia, Kemerovo Region., Novokuznetsk, w. Kuznetsk, 3.

Conditions of supply of pharmacies

On prescription.

Storage conditions of Metoprolol Organica

In the dark place at a temperature no higher than 25 ° C.

Keep out of the reach of children.

Shelf life

3 years.

Do not use beyond the expiration date printed on the package.

Someone from the Denmark - just purchased the goods:
Genferon Light 125 000 ME 10 pieces